Poster Session 1: Pediatric Disorders
Poster Abstracts
Longhorn Hall E (Exhibit Level 1) (Gaylord Texan)
Prevalence and Impact of Poverty in Pediatric Allogeneic Hematopoetic Stem Cell Transplant
Kira Bona, MD, MPH, Dana-Farber Cancer Institute;
Leslie E. Lehmann, MD, Dana-Farber Cancer Institute;
Wendy B. London, PhD, Boston Children's Hospital;
Joanne Wolfe, MD, MPH, Boston Children's Hospital
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) for Non Malignant Hematologic Disorders (NMHD), Using a Chemotherapy-Only Cytoreductive Regimen and T-Cell Depleted Grafts from Alternative Donors
Farid Boulad, MD, Memorial Sloan-Kettering Cancer Center;
Nancy A Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Susan E. Prockop, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, MD, New York Blood Center;
Rachel Lehrman, BS, Memorial Sloan-Kettering Cancer Center;
Julianne M Ruggiero, NP, Memorial Sloan-Kettering Cancer Center;
Kevin Curran, MD, Memorial Sloan-Kettering Cancer Center;
Rachel Kobos, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center
T-Cell-Replete Haploidentical Stem Cell Transplantation with Post-Transplant Cyclophosphamide for Patients with X-Linked Adrenoleukodystrophy: An Immediate Choice for an Urgent Situation
Juliana Fernandes, Instituto da Criança - HC - FMUSP;
Carmem Bonfim, MD, Federal University of Parana;
Fabio R. Kerbauy, MD, UNIFESP (Universidade Federal de Sao Paulo);
Morgani Rodrigues, Hospital Israelita Albert Einstein;
Alessandro de Moura Almeida, Hospital Israelita Albert Einstein;
Iracema Esteves, Hospital Israelita Albert Einstein;
Jose Mauro Kutner, Hospital Israelita Albert Einstein;
Andreza Feitosa Ribeiro, PhD, Hospital Israelita Albert Einstein;
Fernando Kok, MD, Hospital das Clinicas - FMUSP;
Nelson Hamerschlak, MD, PhD, Hospital Israelita Albert Einstein
Busulfan, Melphalan, and Thiotepa Conditioning for Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) of Pediatric Patients with Acute Leukemia and Central Nervous System (CNS) Disease
Christopher J Forlenza, MD, Memorial Sloan-Kettering Cancer Center;
Rachel Kobos, MD, Memorial Sloan-Kettering Cancer Center;
Nancy A Kernan, MD, Memorial Sloan-Kettering Cancer Center;
Andromachi Scaradavou, MD, New York Blood Center;
Susan E. Prockop, MD, Memorial Sloan-Kettering Cancer Center;
Kevin Curran, MD, Memorial Sloan-Kettering Cancer Center;
Neerav Shukla, MD, Memorial Sloan-Kettering Cancer Center;
Peter G Steinherz, MD, Memorial Sloan-Kettering Cancer Center;
Richard O'Reilly, MD, Memorial Sloan-Kettering Cancer Center;
Farid Boulad, MD, Memorial Sloan-Kettering Cancer Center
Acute Graft Versus Host Disease Following Sibling Donor Transplantation for Thalassemia Major
Biju George, MD, Christian Medical College;
Nisham Pn, Christian Medical College;
Vikram Mathews, MD, Christian Medical College;
Kavitha Lakshmi, MSc, Christian Medical College;
Auro Viswabandya, MD, Christian Medical College;
Aby Abraham, MD, Christian Medical College;
Abhijeet Ganapule, MD, Christian Medical College;
Alok Srivastava, MD, Christian Medical College
Hemorrhagic Cystitis Following Hematopoietic Stem Cell Transplants in Children: Single Center Experience
Amir Ali Hamidieh, MD, Tehran University of Medical Sciences;
Maryam Behfar, M.D., Tehran University of Medical Sciences;
Navid Jabalameli, Tehran University of Medical Sciences;
Arash Jalali, Tehran University of Medical Sciences;
Leila Sharifi Aliabadi, Tehran University of Medical Sciences;
Ashraf sadat Hosseini, Tehran University of Medical Sciences;
Simindokht Basirpanah, Tehran University of Medical Sciences;
Ardeshir Ghavamzadeh, M.D., Tehran University of Medical Sciences
Survival and Neurocognitive Outcomes Following Cranial or Craniospinal Irradiation Plus Total Body Irradiation Prior to Transplantation in Children with CNS Leukemia
Susan M Hiniker, MD, Stanford University;
Rajni Agarwal, MD, Stanford University;
Leslie A Modlin, Stanford University;
Jeremy P Harris, MPhil, Stanford University;
Eileen F Kiamanesh, Stanford University;
Lynn Million, Stanford University;
Christine C Gray, PhD, Stanford University;
Sarah S Donaldson, MD, Stanford University
Eosinophilia, Edema, and Nail Dystrophy: Harbingers of Severe Chronic Graft Versus Host Disease of the Skin in Children
Jennifer T Huang, MD, Boston Children's Hospital;
Leslie Lehmann, MD, Dana Farber Cancer Institute;
Christine Duncan, MD, Dana-Farber Cancer Institute;
Arturo Saavedra, MD, PhD, MBA, Brigham and Women's Hospital
Changes in Red Blood Cell Mean Corpuscular Volume after Pediatric HSCT
Amr Qudeimat, MD, Medical University of South Carolina;
Wei Wei, Medical University of South Carolina;
Elizabeth Garrett-Mayer, PhD, Medical University of South Carolina;
John Lazarchick, MD, Medical University of South Carolina;
Michelle Hudspeth, MD, Medical University of South Carolina
Superior Survival Rate Following Conditioning with Etoposide in Childhood ALL
Marianne Ifversen, MD, PhD, Rigshospitalet, Copenhagen University Hospital;
Jacek Winiarski, MD, PhD, Karolinska Institutet, Karolinska University Hospital , Huddinge;
Ulla Saarinen-Pihkala, Children’s Hospital, University of Helsinki;
Karin Mellgren, Institution for Clinical Sciences, University of Gothenburg;
Anders Glomstein, Rikshospitalet, Oslo;
Johan Arvidson, Uppsala University Hospital;
Paivi Lähtenmaaki, Turku University Hospital;
Jacek Toporski, Lund University Hospital;
Susanne Rosthoej, Copenhagen University;
Mats Heyman, Karolinska University Hospital;
Carsten Heilmann, Rigshospitalet Copenhagen University Hospital
Bortezomib Is a Successful Therapeutic Agent for Refractory Autoimmune Cytopenias in Children: A Single Center Experience
Pooja Khandelwal, MD, Cincinnati Children's Hospital Medical Center;
Stella M. Davies, MBBS, PhD, Cincinnati Children's Hospital Medical Center;
Rebecca A Marsh, MD, Cincinnati Children's Hospital Medical Center;
Kasiani C. Myers, MD, Cincinnati Children's Hospital Medical Center;
Javier El-Bietar, MD, Cincinnati Children's Hospital Medical Center;
Sharat Chandra, MD, Cincinnati Children's Hospital Medical Center;
Parinda A. Mehta, MD, Cincinnati Children's Hospital Medical Center;
Sonata Jodele, MD, Cincinnati Children's Hospital Medical Center;
Ashish Kumar, MD, PhD, Cincinnati Children's Hospital Medical Center;
Jack Bleesing, MD, PhD, Cincinnati Children's Hospital Medical Center;
Michael Jordan, MD, Cincinnati Children's Hospital Medical Center;
Michael Grimley, MD, Cincinnati Children's Hospital Medical Center;
Ervin Steve Woodle, MD, FACS, University of Cincinnati;
Rita Alloway, Pharm D, University of Cincinnati;
Alexandra Filipovich, MD, Cincinnati Children's Hospital Medical Center
Dose Response Curves Can be Used to Assess Sensitivity of Busulfan (Bu) in Neuroblastoma (NB) Cell Lines
Sana Khan, Medical Student, Ann & Robert H. Lurie Children's Hospital of Chicago;
Marie Olszewski, Med Tech, Ann & Robert H. Lurie Children's Hospital of Chicago;
Sarah Tallman, Ann & Robert H. Lurie Children's Hospital of Chicago;
Christopher Hewlitt, Ann & Robert H. Lurie Children's Hospital of Chicago;
Wei Huang, Medical Tech, Ann & Robert H. Lurie Children's Hospital of Chicago;
Morris Kletzel, MD, FAAP, MBA, Northwestern University Feinberg School of Medicine
Capillary Leak Syndrome in the Pediatric Population: Incidence, Risk Factors and Prognostic VALUE
Giovanna Lucchini, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Julia Daniels, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Jan Sörensen, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Andrea Jarisch, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Eva Rettinger, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Andre Willasch, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Thomas E Klingebiel, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin;
Peter Bader, MD, Klinik für Kinder und Jugendmedizin
Results of Hematopoietic STEM CELL Transplantation for Primary Immunodeficiencies in Children in Mexico: A Multicentric Report
Regina M Marinez del Campo-Navarro, Hospital Civil de Guadalajara Dr. Juan I Menchaca;
Martin Perez-Garcia, Instituto Nacional de Pediatria;
Oscar Gonzalez-Ramella, Hospital Civil de Guadalajara Dr. Juan I Menchaca;
Mariana Campos-Gutierrez, Instituto Nacional de Pediatria;
Dinora Aguilar-Escobedo, Instituto Nacional de Pediatria;
Ana Luisa Orozco-Alvarado, Hospital Civil de Guadalajara Dr. Juan I Menchaca;
Oscar Gonzalez-Llano, Hospital Universitario de Nuevo Leon;
Consuelo Mancias-Guerra, Hospital Universitario de Nuevo Leon;
Maria de los Angeles del Campo-Martinez, Centro Medico Nacional la Raza;
Ines Montero-Ponce, Centro Medico Nacional la Raza;
Felix Gaytan-Morales, Hospital Infantil de Mexico;
Maria Teresa Pompa-Garza, UMAE # 25, Centro Médico Nacional Noreste IMSS;
Teodoro Muñoz-Ronquillo, UMAE # 25, Centro Médico Nacional Noreste IMSS;
Raquel Amador-Sanchez, Hospital General Gabriel Mancera IMSS;
Alberto Olaya-Vargas, Instituto Nacional de Pediatria
Umbilical Cord Blood Transplantation Can be an Effective Therapy for Patients with Primary Immunodeficiency Diseases Who Lack an HLA-Matched Related Donor
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital;
William Shearer, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Jordan Orange, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Howard Rosenblatt, MD, Baylor College of Medicine;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Swati Naik, MD, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Nabil Ahmed, MD, Baylor College of Medicine, Texas Children's Hospital;
Ghadir Sasa, MD, Baylor College of Medicine, Texas Children's Hospital;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Ann M. Leen, PhD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Imelda C Hanson, MD, Baylor College of Medicine, Texas Children's Hospital;
Robert A. Krance, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital
Prevalence of Diseases and Conditions Amenable to Stem Cell Transplant or Infusion Among Families Storing Newborn Stem Cells at a Large Private Cord Blood Bank
Peter Mazonson, MD, MBA, Mazonson & Santas, LLC;
Chris Santas, MBA, Mazonson & Santas, LLC;
Heather Harris, MS, CGC, CBR-Cord Blood Registry;
Heather Brown, MS, CGC, CBR-Cord Blood Registry;
Andrew Mohr, Mazonson & Santas, LLC;
Lindsay Stanley, MPH, Mazonson & Santas, LLC;
Kelin Colberg, MPH, Mazonson & Santas, LLC
Unrelated Umbilical Cord Blood Transplant for Diamond-Blackfan Anemia
Alicia McFarren, MD, Duke University Medical Center;
Kristin Page, MD, Duke University Medical Center;
Suhag Parikh, MD, Duke University Medical Center;
Paul L. Martin, MD, PhD, Duke University Medical Center;
Timothy A Driscoll, MD, Duke University Medical Center;
Joanne Kurtzberg, MD, Duke University Medical Center;
Vinod K. Prasad, MD, Duke University Medical Center
Outcome after Allogeneic Stem Cell Transplant for Patients with Hematological Malignancies and Associated Chromosome 7 Deletions
Swati Naik, MD, Baylor College of Medicine, Texas Children's Hospital;
Fatma Okur, MD, Baylor College of Medicine;
Bilal Omer, MD, Baylor College of Medicine;
Pulivarthi Rao, PhD, Texas Children's Hospital;
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital;
Jesse Wu, PhD, Baylor College of Medicine, Texas Children's Hospital;
Nabil Ahmed, MD, Baylor College of Medicine, Texas Children's Hospital;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Robert A. Krance, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital
Outcome after Stem Cell Transplant in Patients with Dyskeratosis Congenita
Swati Naik, MD, Baylor College of Medicine, Texas Children's Hospital;
Ghadir Sasa, MD, Baylor College of Medicine, Texas Children's Hospital;
Alison Bertuch, MD, PhD, Baylor College of Medicine;
Caridad Martinez, MD, Baylor College of Medicine, Texas Children's Hospital;
Bilal Omer, MD, Baylor College of Medicine;
Carl Allen, MD, PhD, Baylor College of Medicine, Texas Children's Hospital;
Nabil Ahmed, MD, Baylor College of Medicine, Texas Children's Hospital;
Stephen Gottschalk, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Helen E. Heslop, MD, Baylor College of Medicine, Houston Methodist Hospital and Texas Children's Hospital;
Malcolm K. Brenner, MD, PhD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Robert A. Krance, MD, Baylor College of Medicine, Texas Children's Hospital, The Methodist Hospital;
Kathryn Leung, MD, Baylor College of Medicine, Texas Children's Hospital
HLA Identical Siblings Are the Best Donors for Children with ALL
Christina Peters, MD, PhD, St. Anna Children's Hospital;
Andre Schrauder, University Hospital Schleswig-Holstein;
Martin Schrappe, University Hospital Schleswig-Holstein;
Arend von Stackelberg, Charité;
Peter Bader, MD, Klinik für Kinder und Jugendmedizin;
Wolfram Ebell, University Hospital Charite-Virchow;
Peter Lang, MD, PhD, University Children's Hospital Tuebingen;
Bernhard Kremens, University Hospital;
Karl-Walter Sykora, MD, University Hospital;
Ingo Mueller, Universitats-Kinderlinik Hamburg;
Karoline Ehlert, University Children´s Hospital;
Michael Albert, Dr. von Haunersches Kinderspital;
Wolfgang Holter, St. Anna Children's Hospital;
Brigitte Strahm, University of Freiburg;
Susanne Matthes-Martin, MD, St. Anna Children's Hospital;
Roland Meisel, University Hospital;
Tayfun Gungor, MD, University Childrens Hospital;
Bernd Gruhn, Jena University Hospital;
Ansgar Schulz, Universitatsklinikum Ulm Klinik fur Kinder;
Wilhelm Woessmann, MD, Justus Liebig University;
Martin Zimmermann, Hannover Medical School;
Ulrike Poetschger, St. Anna Children's Cancer Research Institute;
Thomas E Klingebiel, Stem Cell Transplantation and Immunology, Klinik für Kinder und Jugendmedizin
Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Outcomes for Juvenile Myelomonocytic Leukemia (JMML), a 15-Year Single Center Experience
Troy C Quigg, DO, MS, Texas Transplant Institute;
Lisa McDonald, DNP, RN, CPNP, Texas Transplant Institute;
Julie Luke, DNP, RN, CPNP, Methodist Children's Hospital;
Ka Wah Chan, MD, Texas Transplant Institute;
Veronica H Jude, MD, Texas Transplant Institute;
Robert Sanders, MD, Texas Transplant Institute
Repeated Dosing of Autologous Cord Blood Is Safe and Feasible in Babies with Congenital Hydrocephalus
Jessica Sun, MD, Duke University Medical Center;
June Allison, RN, CPON, Duke University Medical Center;
Colleen McLaughlin, DNP, Duke University Medical Center;
R. Anne Fitzgerald, RN, Duke University Medical Center;
Barbara Waters-Pick, B.S., MT(ASCP), Duke University Medical Center;
Joanne Kurtzberg, MD, Duke University Medical Center
A Single Center Experience of Haploidentical Stem Cell Transplants in Pediatric Diseases
Poh-Lin Tan, MBBS, NUHS, Singapore;
Mariflor S Villegas, MD, NUHS, Singapore;
Teck-Guan Soh, MSc, NUHS, Singapore;
Ping Law, MSc, NUHS, Singapore;
Allen Yeoh, MBBS, NUHS, Singapore;
Thuan-Chong Quah, MBBS, NUHS, Singapore
Fludarabine, Busulfan and Melphalan Conditioning in Pediatric Myeloid Malignancies Undergoing Hematopoietic Stem Cell Transplantation
Mariflor S Villegas, MD, NUHS, Singapore;
Woon Li Seo, MBBS, NUHS;
Hsin Chieh Chua, NUHS;
Thuan-Chong Quah, MBBS, NUHS, Singapore;
Allen Yeoh, MBBS, NUHS, Singapore;
Poh-Lin Tan, MBBS, NUHS, Singapore
Reduced Intensity Conditioning and Allogeneic Stem Cell Transplantation Followed By Targeted Consolidation Immunotherapy with Gemtuzumab Ozogamicin in Children and Adolescents with CD33+ Acute Myeloid Leukemia
Stacey Zahler, DO, New York Medical College;
Sumith Roy, MBBS, MPH, New York Medical College;
Angela Ricci, MD, Children's Hospital Boston;
Erin Morris, RN, BSN, New York Medical College;
Lauren Harrison, RN, New York Medical College;
Carmella van de Ven, MS, New York Medical College;
Sandra Foley, RN, MSN, CPNP, New York Medical College;
Erin Cooney-Qualter, MD, Mount Sinai Medical School;
Lee Ann Baxter-Lowe, PhD, UCSF;
Olga Militano, PharmD, New York Medical College;
Morris Kletzel, MD, FAAP, MBA, Northwestern University Feinberg School of Medicine;
Mitchell S. Cairo, MD, New York Medical College
